Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance

Costa, Walter Henriques da; Rocha, Rafael Malagoli; Cunha, Isabela Werneck da; Guimaraes, Gustavo Cardoso; Zequi, Stenio de Cássio.
Int. braz. j. urol ; 38(4): 456-465, July-Aug. 2012. tab
Artículo en Inglés | LILACS | ID: lil-649438

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Heavy Metal Enlightens Tumor Immunity.
  3. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  4. Molecular differences in renal cell carcinoma between males and females.
  5. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  6. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  7. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  8. Renal cell carcinoma, part 1.
  9. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
  10. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.